Why Macy's (M) Outpaced the Stock Market Today

Macy's (M) recently closed up 1.8% at $13.60, outperforming broader market indices, despite analysts forecasting significant year-over-year declines for its upcoming September 3, 2025, Q3 earnings, with EPS projected at $0.19 (-64.15%) and revenue at $4.74 billion (-4.02%). While full-year estimates also show substantial drops, a recent 1.57% upward revision in consensus EPS estimates and a discounted forward P/E of 7.37 (vs. industry 17.16) suggest a nuanced outlook, with the stock currently holding a Zacks Rank of #3 (Hold).

Analysis

Macy's (M) stock exhibited short-term strength with a 1.8% gain to $13.60, outpacing broader market indices. This positive daily momentum, however, is set against a backdrop of deeply negative forward-looking fundamental estimates. For its upcoming earnings on September 3, 2025, analysts project a significant 64.15% year-over-year decline in EPS to $0.19 and a 4.02% drop in revenue to $4.74 billion. The full-year outlook is similarly challenged, with consensus estimates pointing to a 31.44% contraction in earnings and a 4.57% decrease in revenue. Despite these forecasts, two factors provide a degree of counterbalance: the Zacks Consensus EPS estimate has been revised 1.57% higher over the last month, a metric considered a positive leading indicator for near-term stock performance. Furthermore, Macy's currently trades at a substantial valuation discount, with a forward P/E ratio of 7.37 versus an industry average of 17.16. This combination of weak guidance, a recent positive estimate revision, and a low valuation within a strong industry group (ranked in the top 13% by Zacks) culminates in its current Zacks Rank of #3 (Hold), reflecting a state of equilibrium between bearish fundamentals and potential value.

Key Decisions for Investors

• Investors should weigh the deeply discounted valuation against the severe projected declines in earnings and revenue, as the low forward P/E of 7.37 may either represent a value opportunity or a potential value trap pending operational turnaround.
• Closely monitor any further analyst estimate revisions leading up to the September earnings report, as the recent 1.57% upward revision is a key, albeit modest, positive signal that could indicate shifting sentiment among analysts.
• Given the conflicting signals of a Zacks #3 (Hold) rating, poor fundamental forecasts, and a low valuation, a neutral or hold stance is warranted until the company provides definitive guidance on its performance and outlook.
• Consider the stock's performance relative to its industry, which ranks in the top 13%; persistent underperformance despite a strong industry backdrop could be a significant red flag regarding company-specific execution.